BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27512981)

  • 1. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells.
    Hollmann C; Werner S; Avota E; Reuter D; Japtok L; Kleuser B; Gulbins E; Becker KA; Schneider-Schaulies J; Beyersdorf N
    J Immunol; 2016 Oct; 197(8):3130-3141. PubMed ID: 27638864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ Foxp3+ regulatory T cell-mediated immunomodulation by anti-depressants inhibiting acid sphingomyelinase.
    Schneider-Schaulies J; Beyersdorf N
    Biol Chem; 2018 Sep; 399(10):1175-1182. PubMed ID: 29908119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo.
    Kue CS; Lim HX; Jung MY; Hong HJ; Cho D; Kim TS
    Immunobiology; 2013 Jul; 218(7):952-9. PubMed ID: 23313049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
    Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
    J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection.
    Moore C; Tejon G; Fuentes C; Hidalgo Y; Bono MR; Maldonado P; Fernandez R; Wood KJ; Fierro JA; Rosemblatt M; Sauma D; Bushell A
    Eur J Immunol; 2015 Feb; 45(2):452-63. PubMed ID: 25381698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production.
    Shen E; Zhao K; Wu C; Yang B
    Cell Biol Int; 2011 Jul; 35(7):705-12. PubMed ID: 21314640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism.
    Xu A; Liu Y; Chen W; Wang J; Xue Y; Huang F; Rong L; Lin J; Liu D; Yan M; Li QZ; Li B; Song J; Olsen N; Zheng SG
    J Immunol; 2016 May; 196(9):3631-41. PubMed ID: 27001954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
    Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
    Front Immunol; 2018; 9():125. PubMed ID: 29456534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway.
    Zhang Q; Cui F; Fang L; Hong J; Zheng B; Zhang JZ
    J Mol Cell Biol; 2013 Apr; 5(2):85-98. PubMed ID: 23243069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses.
    Bai A; Kokkotou E; Zheng Y; Robson SC
    Cell Death Dis; 2015 Jul; 6(7):e1828. PubMed ID: 26203857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Lck/Fyn kinase activity promotes the differentiation of induced Treg cells through AKT/mTOR pathway.
    Qin Z; Hou P; Lin H; Chen M; Wang R; Xu T
    Int Immunopharmacol; 2024 Jun; 134():112237. PubMed ID: 38744170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1.
    Hsu P; Santner-Nanan B; Hu M; Skarratt K; Lee CH; Stormon M; Wong M; Fuller SJ; Nanan R
    J Immunol; 2015 Oct; 195(8):3665-74. PubMed ID: 26363058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.